These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 24635973)

  • 1. Drug Policy Governance in the UK: lessons from changes to and debates concerning the classification of cannabis under the 1971 Misuse of Drugs Act.
    Monaghan M
    Int J Drug Policy; 2014 Sep; 25(5):1025-30. PubMed ID: 24635973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based policy? The re-medicalization of cannabis and the role of expert committees in the UK, 1972-1982.
    Taylor SL
    Int J Drug Policy; 2016 Nov; 37():129-135. PubMed ID: 27477790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is good governance in the context of drug policy?
    Singleton N; Rubin J
    Int J Drug Policy; 2014 Sep; 25(5):935-41. PubMed ID: 24768218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making drug policy together: reflections on evidence, engagement and participation.
    Roberts M
    Int J Drug Policy; 2014 Sep; 25(5):952-6. PubMed ID: 24882708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Getting to grips with the cannabis problem: the evolving contributions and impact of Griffith Edwards.
    Hall W
    Addiction; 2015 Jul; 110 Suppl 2():36-9. PubMed ID: 26042566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug policy reform and the reclassification of cannabis in England and Wales: A cautionary tale.
    Shiner M
    Int J Drug Policy; 2015 Jul; 26(7):696-704. PubMed ID: 25959525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is UK drug policy evidence based?
    Bennett T; Holloway K
    Int J Drug Policy; 2010 Sep; 21(5):411-7. PubMed ID: 20347288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards good governance in drug policy: evidence, stakeholders and politics.
    MacGregor S; Singleton N; Trautmann F
    Int J Drug Policy; 2014 Sep; 25(5):931-4. PubMed ID: 25086908
    [No Abstract]   [Full Text] [Related]  

  • 9. The latest buzz on medicinal marijuana: a legal and medical perspective.
    Steinborn JJ; Chinn AK; Carter GT
    Am J Hosp Palliat Care; 2001; 18(5):295, 298. PubMed ID: 11565181
    [No Abstract]   [Full Text] [Related]  

  • 10. Attitudes of cannabis growers to regulation of cannabis cultivation under a non-prohibition cannabis model.
    Lenton S; Frank VA; Barratt MJ; Dahl HV; Potter GR
    Int J Drug Policy; 2015 Mar; 26(3):257-66. PubMed ID: 25181993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional considerations.
    Nadelmann E; Gutwillig S; Davies J
    Addiction; 2012 May; 107(5):873-5. PubMed ID: 22471566
    [No Abstract]   [Full Text] [Related]  

  • 12. Governance in EU illicit drugs policy.
    Edwards C; Galla M
    Int J Drug Policy; 2014 Sep; 25(5):942-7. PubMed ID: 25060612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creating the cannabis user: a post-structuralist analysis of the re-classification of cannabis in the United Kingdom (2004-2005).
    Acevedo B
    Int J Drug Policy; 2007 May; 18(3):177-86. PubMed ID: 17689364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The international dimension of drug policy reform in Uruguay.
    von Hoffmann J
    Int J Drug Policy; 2016 Aug; 34():27-33. PubMed ID: 27233516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How do drug policy makers access research evidence?
    Ritter A
    Int J Drug Policy; 2009 Jan; 20(1):70-5. PubMed ID: 18226519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public health issue brief: medical marijuana: year end report-2004.
    Varma P
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-9. PubMed ID: 15765574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations to the Dutch cannabis toleration policy: Assumptions underlying the reclassification of cannabis above 15% THC.
    Van Laar M; Van Der Pol P; Niesink R
    Int J Drug Policy; 2016 Aug; 34():58-64. PubMed ID: 27471078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenges in developing a rational cannabis policy.
    Hall W; Lynskey M
    Curr Opin Psychiatry; 2009 May; 22(3):258-62. PubMed ID: 19293714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of medical marijuana.
    Das R
    JAMA; 2005 Dec; 294(24):3091; author reply 3091-2. PubMed ID: 16380588
    [No Abstract]   [Full Text] [Related]  

  • 20. Capitalising upon political opportunities to reform drug policy: a case study into the development of the Australian "Tough on Drugs-Illicit Drug Diversion Initiative".
    Hughes CE
    Int J Drug Policy; 2009 Sep; 20(5):431-7. PubMed ID: 19162458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.